Wego, the number 1 travel app and largest travel marketplace in the Middle East and North Africa (MENA), is excited to ...
During the period of "HONGQI Global Partners Gathering 2024" , HONGQI invited three families from Europe , the Middle East, ...
XRP Healthcare, a pioneering company at the intersection of blockchain and healthcare, has announced a strategic move to halt ...
The Asia-focused mid-market buyout fund, which had an initial target size of USD 750 million, closes with USD 1.6 billion in total fund commitments, of which USD 1.4 billion is fee-generatingThe ...
Between 20 May 2024 and 24 May 2024 EQT AB (LEI code 213800U7P9GOIRKCTB34) ("EQT") has repurchased 564,766 own ordinary shares (ISIN: SE0012853455). In ...
GOTHENBURG, SE / ACCESSWIRE / May 27, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden. May 27, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A) - a company discovering and ...
ATLANTA, GA / ACCESSWIRE / May 27, 2024 / Starrscreen, a leader in business growth solutions, is transforming the landscape for small and medium-sized enterprises with its innovative approach and unwa ...
EXPLORATION UPDATE FOR MEYAS SAND GOLD PROJECT - SUDAN Perth, Western Australia/ May 27, 2024/Perseus Mining Limited (ASX/TSX: PRU) is pleased to provide an update ...
BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - European stocks may open a tad lower on Monday, with trading volumes likely to remain thin due to Memorial Day holiday in the U.S. Asian markets traded mostly ...
Renewed partnership combines best in class engineering capabilities with cutting edge science to accelerate the availability of new solutions for customers and patients worldwide Upcoming launches of ...
- Launch of ASEAN Stone to provide for the rising demand from the commercial, residential, industrial and infrastructure sectors - ASEAN Stone 2024 Exhibition, co-locating with ASEAN Ceramics in ...
Sarclisaaccepted for FDA priority review for the treatment of transplant-ineligible newly diagnosed multiple myeloma FDA Priority Review granted based on positive results from IMROZ phase 3 study If ...